Online weight loss treatment in Louisiana
Surfbound connects eligible adults in Louisiana with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in Louisiana?
Yes. Eligible adults across Louisiana can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in Louisiana reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Louisiana address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Pelican State · South / Gulf region. High obesity prevalence and uneven specialist access across parishes. Online review avoids travel across the state.
Cities in Louisiana
Coverage across Louisiana
Surfbound lists 6 Louisiana cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to Louisiana
Prescriptions for Louisiana patients are routed to a licensed compounding pharmacy. Dispatch follows provider approval, and delivery time varies with distance across the South / Gulf region, from New Orleans, Baton Rouge, Shreveport to rural addresses, plus pharmacy and carrier schedules. Tracking is provided by email.
What's included in every Louisiana plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
Louisiana coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in Louisiana. The Louisiana provider access & process page covers the clinical steps in detail.
Surfbound lists 6 Louisiana cities with a dedicated local page. Because care is delivered online, you can start from anywhere in Louisiana — the city list is a navigation aid, not a limit on where you can begin.
The Louisiana telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Louisiana. You complete a health intake online, and a licensed provider credentialed in Louisiana reviews your information remotely.
Louisiana permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Louisiana may review a Louisiana patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Louisiana” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Louisiana license issued by the Louisiana State Board of Medical Examiners, and any pharmacy filling your prescription must be licensed in Louisiana. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Louisiana” section on this page.
Louisiana residents pay $169/mo for compounded semaglutide or $219/mo for compounded tirzepatide, provider review included. Compounded medications are not FDA-approved, and the price is displayed before you pay.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
No — in Louisiana, medication is dispensed only when the reviewing provider finds treatment medically appropriate.
Yes. Louisiana patients already taking a GLP-1 can request a dose match when clinically appropriate. Sign up and use the doctor-notes field at the end of the form to list your current medication and dose, and whether you want to stay at that dose or discuss increasing it. Your Louisiana-licensed clinician reviews the request and determines the prescription. No written quote is required to switch.
The GLP-1 total-cost calculator compares equal monthly recurring cost — membership, shipping and dose surcharges for any plan — against Surfbound's flat Louisiana rate, so Louisiana residents compare complete costs rather than a headline number.
Compounded semaglutide is one of the two GLP-1 options available across Louisiana, priced flat each month with the provider review included. Nothing ships unless a Louisiana-licensed provider approves treatment. It is not an FDA-approved medication.
Compounded tirzepatide is part of the Louisiana offering, priced flat each month with delivery included. Whether it is the right option is a clinical decision made by a Louisiana-licensed provider, and it is not an FDA-approved medication.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Louisiana residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Louisiana-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Louisiana. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Louisiana provider approves your medication. High obesity prevalence and uneven specialist access across parishes.
Yes. Louisiana residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Louisiana provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Louisiana with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A Louisiana-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. Louisiana residents complete a short online intake on their own schedule, and a Louisiana-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. High obesity prevalence and uneven specialist access across parishes. Online review avoids travel across the state.
Yes. Men across Louisiana begin with a private online intake, a licensed Louisiana provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Louisiana residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in Louisiana
What governs a provider treating a Louisiana patient online, and where you can check it yourself.
State medical board
Louisiana State Board of Medical ExaminersLouisiana State Board of Medical Examiners licenses the providers who review Louisiana intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
Louisiana Telehealth Access Act (La. R.S. 37:1261-1293)Opens the official Louisiana code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active Louisiana license to evaluate or treat a patient who is physically located in Louisiana. Every Louisiana intake is routed to a provider credentialed in Louisiana, and a prescription is issued only when that provider determines treatment is medically appropriate.
Louisiana permits telemedicine prescribing when a provider-patient relationship has been established through a proper evaluation. The Surfbound online health intake and provider review satisfies this requirement.
Surfbound is an online service. We do not have physical offices in Louisiana. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in Louisiana and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Louisiana state government agency. Provider licensure in Louisiana is governed by the Louisiana State Board of Medical Examiners.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.